Home>Topics>>St. Jude Medical shares slide 13 percent on FDA report

St. Jude Medical shares slide 13 percent on FDA report

Reuters: Global Markets

Wed, 21 Nov 2012

(Reuters) - Shares of St. Jude Medical tumbled more than 13 percent on Wednesday as a report by U.S. health regulators raised fresh safety concerns about one of the company's leads used with...
Content Partners